# Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department

## Authors

- Oya Akpinar Oruc ([ORCID](https://orcid.org/0000-0003-2515-0956)) — Department of Emergency Medicine, School of Medicine, Afyonkarahisar Health
- Serife Ozdinc ([ORCID](https://orcid.org/0000-0003-3948-8501)) — Department of Emergency Medicine, School of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
- Hulya Sevil ([ORCID](https://orcid.org/0000-0002-3536-3253)) — Department of Emergency Medicine, School of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 9, Issue 3 (2023), pages 128–136
- **Article type:** Original Article
- **Published online:** 2023-09-13
- **DOI:** [10.5455/umj.20230822072102](https://doi.org/10.5455/umj.20230822072102)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=166475
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/166475.pdf

## Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) exacerbations present significant challenges in emergency care settings. Predictive tools like the Ottawa Risk Scale (ORS) can potentially enhance early patient management. We aimed to assess the reliability and efficiency of the ORS among COPD in emergency departments. Materials and Methods: The study reviewed 75 patients presenting with COPD exacerbations were evaluated using the ORS. The ORS categorized patients into four risk groups: Low, Medium, High, and Very High. Clinical characteristics, blood gas analyses, and imaging results were documented. Results: Clinical symptoms were prevalent across all risk categories, but a significant association was found between smoking history and ORS categorization (p=0.042), oxygen saturation levels (p=0.043), initial PaO2 levels (p=0.013), initial and post-treatment PaCO2 (p=0.008, p=0.003 respectively), and pathological X-ray findings (p=0.005). The mMRC scale showed a correlation with ORS categorization (p=0.0001). The High and Very High-risk groups had higher hospitalization rates and adverse outcomes than Low and Medium risk. Conclusion: The ORS is a promising tool for predicting short-term adverse outcomes in COPD within emergency settings. This study underscores its potential utility in aiding clinical decision-making, guiding interventions, and improving patient outcomes.

## Keywords

COPD exacerbations; Ottawa risk scale; emergency department; mMRC scale

## How to cite

Oruc OA, Ozdinc S, Sevil H. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. Ulutas Med J. 2023;9(3):128-136. doi:10.5455/umj.20230822072102

## References

1. Alqahtani JS, Aldhahir AM, Alghamdi SM, Al Ghamdi SS, AlDraiwiesh IA, Alsulayyim AS, et al. A systematic review and meta-analysis of heart rate variability in COPD. Front Cardiovasc Med. 2023;10:1070327. https://doi.org/10.3389/fcvm.2023.1070327
2. Wang J, Li X, Lei S, Zhang D, Zhang S, Zhang H, et al. Risk of dementia or cognitive impairment in COPD patients: A meta-analysis of cohort studies. Front Aging Neurosci. 2022;14:962562. https://doi.org/10.3389/fnagi.2022.962562
3. Zhang J, Perret JL, Chang AB, Idrose NS, Bui DS, Lowe AJ, et al. Risk factors for chronic cough in adults: A systematic review and meta-analysis. Respirology. 2022;27(1):36-47. https://doi.org/10.1111/resp.14169
4. Lv H, Huang J, Miao M, Huang C, Hang W, Xu Y. Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ Open Respir Res. 2023;10(1). https://doi.org/10.1136/bmjresp-2022-001569
5. Ruan H, Zhang H, Wang J, Zhao H, Han W, Li J. Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir Med. 2023;206:107090. https://doi.org/10.1016/j.rmed.2022.107090
6. Sami R, Savari MA, Mansourian M, Ghazavi R, Meamar R. Effect of Long-Term Oxygen Therapy on Reducing Rehospitalization of Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Pulm Ther. 2023;9(2):255-70. https://doi.org/10.1007/s41030-023-00221-3
7. Liao Y, Liao Y, Wen F. Association of human Hedgehog interacting protein gene polymorphisms with the risk of chronic obstructive pulmonary disease: a meta-analysis. Expert Rev Respir Med. 2022;16(4):447-59. https://doi.org/10.1080/17476348.2022.2030226
8. Gupta S, Panchal P, Sadatsafavi M, Ghanouni P, Sin D, Pakhale S, et al. A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study. Addict Sci Clin Pract. 2022;17(1):1. https://doi.org/10.1186/s13722-021-00283-1
9. Gao YC, Zhang YW, Shi L, Gao W, Li YJ, Chen H, et al. What are Risk Factors of Postoperative Pneumonia in Geriatric Individuals after Hip Fracture Surgery: A Systematic Review and Meta-Analysis. Orthop Surg. 2023;15(1):38-52. https://doi.org/10.1111/os.13631
10. Fortis S, Shannon ZK, Garcia CJ, Guillamet RV, Aloe AM, Schweizer ML, et al. Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysis. Chest. 2022;162(1):92 -100. https://doi.org/10.1016/j.chest.2022.02.003
11. Alavi-Moghaddam M, Partovinezhad H, Dasdar S, Farjad M. Ottawa Risk Scale in Predicting the Outcome of Chorionic Obstructive Pulmonary Disease Exacerbation in Emergency Department; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2023;11(1):e32.
12. Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5). https://doi.org/10.1183/13993003.01261-2018
13. Unal A, Bayram B, Ergan B, Can K, Ergun YK, Kilinc O. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score. ERJ Open Res. 2023;9(2). https://doi.org/10.1183/23120541.00436-2022
14. Ali U, Basak B, Begum E, Kazim C, Yagiz Kagan E, Oguz K. Comparison of Two Scores for Short Term Outcomes in Patients with COPD Exacerbation in ED: The Ottawa COPD Risk Scale and the DECAF Score. ERJ Open Research. 2022:00436-2022. 136 77 Ottawa Risk Scale in Assessing COPD Oruc et al.
15. Hale MKP, Stiell IG, Clement CM. Emergency Department Management of Heart Failure and COPD: A National Survey of Attitudes and Practice. CJEM. 2016;18(6):429-36. https://doi.org/10.1017/cem.2016.24
16. Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, et al. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. Cmaj. 2014;186(6):E193-204. https://doi.org/10.1503/cmaj.130968
